Access cutting-edge ovarian cancer treatment through this clinical trial at a research site in Middletown. Study-provided care at no cost to qualified participants.
Access ovarian cancer specialists in Middletown at no cost
This study follows strict safety protocols and ethical guidelines
All study-related ovarian cancer treatment provided free
Participants will be scheduled for primary cytoreductive surgery as part of their standard care. Before surgery, participants will be assigned by chance to a study group. Depending on which group they are in, they will receive either acute normovolemic hemodilution/ANH during surgery or standard surgical management during surgery. The researchers think acute normovolemic hemodilution/ANH may decrease the need for allogenic blood transfusion/ABT in people having primary cytoreductive surgery.
Sponsor: Memorial Sloan Kettering Cancer Center
Check if you qualify for this ovarian cancer clinical trial in Middletown, NJ
If you're searching for ovarian cancer treatment options in Middletown, NJ, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Middletown research site is actively enrolling participants for this clinical trial. You'll receive care from experienced ovarian cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.